A postnatal pax7+ progenitor gives rise to pituitary adenomas

Genes and Cancer

Volumn 1, Issue 4, 2010, Pages 388-402

  Hosoyama, Tohru ^a   Nishijo, Koichi ^a   Garcia, Melinda M ^a   Schaffer, Beverly S ^a   Ohshima Hosoyama, Sachiko ^a   Prajapati, Suresh I ^a   Davis, Michael D ^a   Grant, Wilmon F ^b   Scheithauer, Bernd W ^c   Marks, Daniel L ^b   Rubin, Brian P ^d   Keller, Charles ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c MAYO CLINIC   (United States)

^d TAUSSIG CANCER INSTITUTE   (United States)

Author keywords

Corticotroph; Melanotroph; Myf6; Pax7; Pituitary macro adenoma; pRb

Indexed keywords

MYOGENIC FACTOR; MYOGENIC FACTOR 6; NESTIN; TRANSCRIPTION FACTOR PAX7; UNCLASSIFIED DRUG;

ACTH SECRETING ADENOMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER STEM CELL; CELL DIFFERENTIATION; CELL LINEAGE; CELL RENEWAL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENETIC CONSERVATION; HYPOPHYSIS INTERMEDIATE LOBE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TUMOR CELL;

MURINAE; PRIMATES;

EID: 77956264392     PISSN: 19476019     EISSN: 19476027     Source Type: Journal    
DOI: 10.1177/1947601910370979     Document Type: Article

References (68)

1. Celio MR, Pasi A, Bürgisser E, Buetti G, Höllt V, Gramsch C. Proopiocortin fragments in normal human adult pituitary: distribution and ultrastructural characterization of immunoreactive cells. Acta Endocrinol 1980;95:27-40.
2. Hall WA, Luciano MG, Doppman JL, Patronas NJ, Oldfield EH. Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population. Ann Intern Med 1994;120:817-20.
3. Greenman Y, Melmed S. Diagnosis and management of nonfunctioning pituitary tumors. Annu Rev Med 1996;47:95-106.
4. Laws ER, Jane JA Jr. Pituitary tumors: long-term outcomes and expectations. Clin Neurosurg 2001;48:306-19.
5. Melmed S. Mechanisms for pituitary tumorigenesis: the plastic p ituitary. J Clin Invest 2003;112:1603-18.
6. Lloyd RV, Kovacs K, Young WF, Farrel WE, Asa SL, Trouillas J, et al. Tumours of the pituitary. In: World Health Organization classification of tumours. Pathology and genetics of tumours of endocrine organs. Geneva, Switzerland: World Health Organization; 2004. p. 10-47.
7. Horvath E, Kovacs K, Killinger DW, Smyth HS, Platts ME, Singer W. Silent corticotropic adenomas of the human pituitary gland: a histologic, immunocytologic, and ultrastructural study. Am J Pathol 1980;98:617-38.
8. Reincke M, Allolio B, Saeger W, Kaulen D, Winkelmann W. A pituitary adenoma secreting high molecular weight adrenocorticotropin without evidence of Cushing's disease. J Clin Endocrinol Metab 1987;65:1296-300.
9. Zhu X, Gleiberman AS, Rosenfeld MG. Molecular physiology of pituitary development: signaling and transcriptional networks. Physiol Rev 2007;87:933-63.
10. Lamolet B, Pulichino AM, Lamonerie T, Gauthier Y, Brue T, Enjalbert A, et al. A pituitary cell-restricted T box factor, Tpit, activates POMC transcription in cooperation with Pitx homeoproteins. Cell 2001;104:849-59.
11. Liu J, Lin C, Gleiberman A, Ohgi KA, Herman T, Huang HP, et al. Tbx19, a tissue-selective regulator of POMC gene expression. Proc Natl Acad Sci USA 2001;98:8674-9.
12. Pulichino AM, Vallette-Kasic S, Couture C, Gauthier Y, Brue T, David M, et al. Human and mouse TPIT gene mutations cause early onset pituitary ACTH deficiency. Genes Dev 2003;17:711-6.
13. Raetzman LT, Cai JX, Camper SA. Hes1 is required for pituitary growth and melanotrope specification. Dev Biol 2007;304:455-66.
14. Gleiberman AS, Michurina T, Encinas JM, Roig JL, Krasnov P, Balordi F, et al. Genetic approaches identify adult pituitary stem cells. Proc Natl Acad Sci USA 2008;105:6332-7.
15. Fauquier T, Rizzoti K, Dattani M, Lovell-Badge R, Robinson IC. SOX2-expressing progenitor cells generate all of the major cell types in the adult mouse pituitary gland. Proc Natl Acad Sci USA 2008;105:2907-12.
16. Hill RE, Favor J, Hogan BL, Ton CC, Saunders GF, Hanson IM, et al. Mouse small eye results from mutations in a paired-like homeoboxcontaining gene. Nature 1991;354:522-5.
17. Walther C, Gruss P. Pax-6, a murine paired box gene, is expressed in the developing CNS. Development 1991;113:1435-49.
18. Seale P, Sabourin LA, Girgis-Gabardo A, Mansouri A, Gruss P, Rudnicki MA. Pax7 is required for the specification of myogenic satellite cells. Cell 2000;102:777-86.
19. Oustanina S, Hause G, Braun T. Pax7 directs postnatal renewal and propagation of myogenic satellite cells but not their specification. EMBO J 2004;23:3430-9.
20. Scully KM, Rosenfeld MG. Pituitary development: regulatory codes in mammalian organogenesis. Science 2002;295:2231-5.
21. Taniguchi Y, Kominami R, Yasutaka S, Kawarai Y. Proliferation and differentiation of pituitary corticotrophs during the fetal and postnatal period: a quantitative immunocytochemical study. Anat Embryol (Berl) 2000;201:229-34.
22. Rinehart JF, Farquhar MG. Electron microscopic studies of the anterior pituitary gland. J Histochem Cytochem 1953;1:93-113.
23. Chen J, Hersmus N, Van Duppen V, Caesens P, Denef C, Vankelecom H. The adult pituitary contains a cell population displaying stem/ progenitor cell and early embryonic characteristics. Endocrinology 2005;146:3985-3998.
24. Hayashi S, McMahon AP. Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse. Dev Biol 2002;244:305-18.
25. Nishijo K, Hosoyama T, Bjornson CR, Schaffer BS, Prajapati SI, Bahadur AN, et al. Biomarker system for studying muscle, stem cells, and cancer in vivo. FASEB J 2009;23:2681-90.
26. Poulin G, Turgeon B, Drouin J. NeuroD1/beta2 contributes to cellspecific transcription of the proopiomelanocortin gene. Mol Cell Biol 1997;17:6673-82.
27. Lamolet B, Poulin G, Chu K, Guillemot F, Tsai MJ, Drouin J. Tpitindependent function of NeuroD1(BETA2) in pituitary corticotroph differentiation. Mol Endocrinol 2004;18:995-1003.
28. Lassar AB, Paterson BM, Weintraub H. Transfection of a DNA locus that mediates the conversion of 10T1/2 fibroblasts to myoblasts. Cell 1986;47:649-56.
29. Wright WE, Sassoon DA, Lin VK. Myogenin, a factor regulating myogenesis, has a domain homologous to MyoD. Cell 1989;56:607-17.
30. Braun T, Winter B, Bober E, Arnold HH. Transcriptional activation domain of the muscle-specific gene-regulatory protein myf5. Nature 1990;346:663-5.
31. Braun T, Bober E, Winter B, Rosenthal N, Arnold HH. Myf-6, a new member of the human gene family of myogenic determination factors: evidence for a gene cluster on chromosome 12. EMBO J 1990;9:821-31.
32. Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA, Weinberg RA. Effects of an Rb mutation in the mouse. Nature 1992;359:295-300.
33. Nikitin AY, Juáez-Pérez MI, Li S, Huang L, Lee WH. RB-mediated suppression of spontaneous multiple neuroendocrine neoplasia and lung metastases in Rb+/- mice. Proc Natl Acad Sci USA 1999;96:3916-21.
34. Vooijs M, van der Valk M, te Riele H, Berns A. Flp-mediated tissuespecific inactivation of the retinoblastoma tumor suppressor gene in the mouse. Oncogene 1998;17:1-12.
35. Nikitin AY, Lee WH. Early loss of the retinoblastoma gene is associated with impaired growth inhibitory innervation during melanotroph carcinogenesis in Rb+/- mice. Genes Dev 1996;10:1870-9.
36. Keller C, Arenkiel BR, Coffin CM, El-Bardeesy N, DePinho RA, Capecchi MR. Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice: cooperativity of Ink4a/ARF and Trp53 loss of function. Genes Dev 2004;18:2614-26.
37. Asa SL, Ezzat S. The cytogenesis and pathogenesis of pituitary adenomas. Endocr Rev 1998;19:798-827.
38. Benjannet S, Rondeau N, Day R, Chrétien M, Seidah NG. PC1 and PC2 are proprotein convertases capable of cleaving proopiomelanocortin at distinct pairs of basic residues. Proc Natl Acad Sci USA 1991;88:3564-8.
39. Thomas L, Leduc R, Thorne BA, Smeekens SP, Steiner DF, Thomas G. Kex2-like endoproteases PC2 and PC3 accurately cleave a model prohormone in mammalian cells: evidence for a common core of neuroendocrine processing enzymes. Proc Natl Acad Sci USA 1991;88:5297-301.
40. Zhou A, Bloomquist BT, Mains RE. The prohormone convertases PC1 and PC2 mediate distinct endoproteolytic cleavages in a strict temporal order during proopiomelanocortin biosynthetic processing. J Biol Chem 1993;268:1763-9.
41. Marcinkiewicz M, Day R, Seidah NG, Chrétien M. Ontogeny of the prohormone convertases PC1 and PC2 in the mouse hypophysis and their colocalization with corticotropin and alpha-melanotropin. Proc Natl Acad Sci USA 1993;90:4922-6.é
42. Alvaro V, Lévy L, Dubray C, Roche A, Peillon F, Quérat B, et al. Invasive human pituitary tumors express a point-mutated alpha-protein kinase-C. J Clin Endocrinol Metab 1993;77:1125-9.
43. Heaney AP, Horwitz GA, Wang Z, Singson R, Melmed S. Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis. Nat Med 1999;5:1317-21.
44. Japón MA, Urbano AG, Sáez C, Segura DI, Cerro AL, Diéguez C, et al. Glial-derived neurotropic factor and RET gene expression in normal human anterior pituitary cell types and in pituitary tumors. J Clin Endocrinol Metab 2002;87:1879-1884.
45. McFerran BW, MacEwan DJ, Guild SB. Involvement of multiple protein kinase C isozymes in the ACTH secretory pathway of AtT-20 cells. Br J Pharmacol 1995;115:307-15.
46. Riss D, Jin L, Qian X, Bayliss J, Scheithauer BW, Young WF Jr, et al. Differential expression of galectin-3 in pituitary tumors. Cancer Res 2003;63:2251-5.
47. Takahashi C, Contreras B, Iwanaga T, Takegami Y, Bakker A, Bronson RT, et al. Nras loss induces metastatic conversion of Rb1-deficient neuroendocrine thyroid tumor. Nat Genet 2006;38:118-23.
48. Thodou E, Argyrakos T, Kontogeorgos G. Galectin-3 as a marker distinguishing functioning from silent corticotroph adenomas. Hormones (Athens) 2007;6:227-32.
49. Bentley CA, Zidehsarai MP, Grindley JC, Parlow AF, Barth-Hall S, Roberts VJ. Pax6 is implicated in murine pituitary endocrine function. Endocrine 1999;10:171-7.
50. Kioussi C, O'Connell S, St-Onge L, Treier M, Gleiberman AS, Gruss P, et al. Pax6 is essential for establishing ventral-dorsal cell boundaries in pituitary gland development. Proc Natl Acad Sci USA 1999;96:14378-82.
51. Jostes B, Walther C, Gruss P. The murine paired box gene, Pax7, is expressed specifically during the development of the nervous and muscular system. Mech Dev 1990;33:27-37.
52. Stoykova A, Gruss P. Roles of Pax-genes in developing and adult brain as suggested by expression patterns. J Neurosci 1994;14: 1395-1412.
53. Ziman MR, Fletcher S, Kay PH. Alternate Pax7 transcripts are expressed specifically in skeletal muscle, brain and other organs of adult mice. Int J Biochem Cell Biol 1997;29:1029-36.
54. Taniguchi E, Cho MJ, Arenkiel BR, Hansen MS, Rivera OJ, McCleish AT, et al. Bortezomib reverses a post-translational mechanism of tumorigenesis for patched1 haploinsufficiency in medulloblastoma. Pediatr Blood Cancer 2009;53:136-44.
55. Guner B, Ozacar AT, Thomas JE, Karlstrom RO. Graded hedgehog and fibroblast growth factor signaling independently regulate pituitary cell fates and help establish the pars distalis and pars intermedia of the zebrafish adenohypophysis. Endocrinology 2008;149:4435-51.
56. Kumar D, Shadrach JL, Wagers AJ, Lassar AB. Id3 is a direct transcriptional target of Pax7 in quiescent satellite cells. Mol Biol Cell 2009;20:3170-7.
57. Hu N, Gutsmann A, Herbert DC, Bradley A, Lee WH, Lee EY. Heterozygous Rb-1 delta 20/+mice are predisposed to tumors of the pituitary gland with a nearly complete penetrance. Oncogene 1994;9:1021-7.
58. Harrison DJ, Hooper ML, Armstrong JF, Clarke AR. Effects of heterozygosity for the Rb-1t19neo allele in the mouse. Oncogene 1995;10:1615-20.
59. Cryns VL, Alexander JM, Klibanski A, Arnold A. The retinoblastoma gene in human pituitary tumors. J Clin Endocrinol Metab 1993;77:644-6.
60. Simpson DJ, Hibberts NA, McNicol AM, Clayton RN, Farrell WE. Loss of pRb expression in pituitary adenomas is associated with methylation of the RB1 CpG island. Cancer Res 2000;60:1211-6.
61. Pei L, Melmed S, Scheithauer B, Kovacs K, Benedict WF, Prager D. Frequent loss of heterozygosity at the retinoblastoma susceptibility gene (RB) locus in aggressive pituitary tumors: evidence for a chromosome 13 tumor suppressor gene other than RB. Cancer Res 1995;55:1613-6.
62. Horvath E, Kovacs K, Lloyd RV. Pars intermedia of the human pituitary revised: Morphologic aspects and frequency of hyperplasia of POMC-peptide immunoreactive cells. Endocr Pathol 1999;10:55-64.
63. Fan X, Olson SJ, Johnson MD. Immunohistochemical localization and comparison of carboxypeptidases D, E, and Z, alpha-MSH, ACTH, and MIB-1 between human anterior and corticotroph cell "basophil invasion" of the posterior pituitary. J Histochem Cytochem 2001;49:783-90.
64. Nagaya T, Kuwayama A, Seo H, Tsukamoto N, Matsui N, Sugita K. Endocrinological evaluation of ACTH-secreting pituitary microadenomas: their location and alpha-melanocyte stimulating hormone immunoreactivity. J Neurosurg 1992;76:944-7.
65. Lamberts SW, de Lange SA, Stefanko SZ. Adrenocorticotropinsecreting pituitary adenomas originate from the anterior or the intermediate lobe in Cushing's disease: differences in the regulation of hormone secretion. J Clin Endocrinol Metab 1982;54:286-91.
66. Soriano P. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet 1999;21:70-71.
67. Srinivas S, Watanabe T, Lin CS, William CM, Tanabe Y, Jessell TM, et al. Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev Biol 2001;1:4.
68. Nishijo K, Chen QR, Zhang L, McCleish AT, Rodriguez A, Cho MJ, et al. Credentialing a preclinical mouse model of alveolar rhabdomyosarcoma. Cancer Res 2009;69:2902-11.